<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Autophagy_Zinc</id>
		<title>Autophagy Zinc - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Autophagy_Zinc"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Autophagy_Zinc&amp;action=history"/>
		<updated>2026-04-07T03:36:19Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Autophagy_Zinc&amp;diff=178289&amp;oldid=prev</id>
		<title>Attack0oak: Створена сторінка: Lee J-H, Hua Lu H Chimeric p53 as an option therapy for hypoxic tumors. Cancer Biol Ther. 11: 108110. 3. Hdeib A,  Sloan AE Convection-enhanced delivery of 131I...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Autophagy_Zinc&amp;diff=178289&amp;oldid=prev"/>
				<updated>2017-05-19T06:06:51Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Lee J-H, Hua Lu H Chimeric p53 as an option therapy for hypoxic tumors. Cancer Biol Ther. 11: 108110. 3. Hdeib A,  Sloan AE Convection-enhanced delivery of 131I...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Lee J-H, Hua Lu H Chimeric p53 as an option therapy for hypoxic tumors. Cancer Biol Ther. 11: 108110. 3. Hdeib A,  Sloan AE Convection-enhanced delivery of 131I-chTNT-1/B mAB for remedy of high-grade adult gliomas. Expert Opin Biol Ther. 11: 799806. 4. Kioi M, Husain SR, Croteau D, Kunwar S, Puri RK Convectionenhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Technol Cancer Res Treat.; five: 23950. 5. Choi JJ, Feshitan JA, Baseri B, Wang S, Tung YS, et al. Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo. IEEE Trans Biomed Eng. 57: 14554. six. Groothuis DR The blood-brain and blood-tumor barriers: a critique of techniques for escalating drug delivery. Differential regulation of leptin transport by the [http://www.medchemexpress.com/Ruxolitinib.html purchase Ruxolitinib] choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. A special carrier for delivery of therapeutic compounds beyond the blood-brain barrier. PLoS A single. three: e2469. 18. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF In vivo protein transduction: delivery of a biologically active protein in to the mouse. Science 285: 15691572. 19. Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, et al. Very penetrative, drug-loaded nanocarriers strengthen remedy of glioblastoma. Proc Natl Acad Sci U S A. 110: 117516. 20. Allard E, Passirani C, Benoit JP Convection-enhanced delivery of nanocarriers for the remedy of brain tumors. Biomaterials 30: 230218. 21. Sarkar G, Curran GL, Mahlum E, Decklever T, Wengenack TM, et al. A carrier for non-covalent delivery of functional beta-galactosidase and antibodies  against amyloid plaques and IgM for the brain. PLoS One particular. 6: e28881. 22. Carlson SK, Classic KL, Hadac EM, Bender CE, Kemphysiology and pathology in the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative issues. J Neurovirol five: 538555. two. Lee J-H, Hua Lu H Chimeric p53  as an alternative therapy for hypoxic tumors. Cancer Biol Ther. 11: 108110. three. Hdeib A, Sloan AE Convection-enhanced delivery of 131I-chTNT-1/B mAB for therapy of high-grade adult gliomas. Expert Opin Biol Ther. 11: 799806. 4. Kioi M, Husain SR, Croteau D, Kunwar S, Puri RK Convectionenhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Technol Cancer Res Treat.; five: 23950. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and higher affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology. 141: 14341441. 12. Spencer BJ, Verma IM Targeted delivery of proteins across the bloodbrain barrier. Proc Natl Acad Sci U S A. 104: 75947599. 13. Wang D, El-Amouri SS, Dai M, Kuan C-Y, Hui DY, et al. Engineering a lysosomal enzyme having a derivative of receptor-binding domain of apoE enables delivery across the bloodbrain barrier. PNAS 110: 29993004. 14. Boado RJ, Hui EK, Lu JZ, Pardridge WM Drug targeting of erythropoietin across [http://www.ncbi.nlm.nih.gov/pubmed/1315463 1315463] the primate blood-brain barrier with an IgG molecular Trojan horse. J Pharmacol Exp Ther. 27: 85131. 17. Karkan D, Pfeifer C, Vitalis TZ, Arthur G, Ujiie M, et al. A exclusive carrier for delivery of therapeutic compounds beyond the blood-brain barrier. PLoS One. 3: e2469.&lt;/div&gt;</summary>
		<author><name>Attack0oak</name></author>	</entry>

	</feed>